• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神分裂症是一种进行性脑疾病的说法是一种谬论。

The myth of schizophrenia as a progressive brain disease.

机构信息

To whom correspondence should be addressed; St Joseph's Healthcare Hamilton, 100 West 5th Street, Hamilton, Ontario L8N3K7, Canada; tel: 905-522-1155 x 36250, fax: 905-381-5633, e-mail:

出版信息

Schizophr Bull. 2013 Nov;39(6):1363-72. doi: 10.1093/schbul/sbs135. Epub 2012 Nov 20.

DOI:10.1093/schbul/sbs135
PMID:23172002
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3796078/
Abstract

Schizophrenia has historically been considered to be a deteriorating disease, a view reinforced by recent MRI findings of progressive brain tissue loss over the early years of illness. On the other hand, the notion that recovery from schizophrenia is possible is increasingly embraced by consumer and family groups. This review critically examines the evidence from longitudinal studies of (1) clinical outcomes, (2) MRI brain volumes, and (3) cognitive functioning. First, the evidence shows that although approximately 25% of people with schizophrenia have a poor long-term outcome, few of these show the incremental loss of function that is characteristic of neurodegenerative illnesses. Second, MRI studies demonstrate subtle developmental abnormalities at first onset of psychosis and then further decreases in brain tissue volumes; however, these latter decreases are explicable by the effects of antipsychotic medication, substance abuse, and other secondary factors. Third, while patients do show cognitive deficits compared with controls, cognitive functioning does not appear to deteriorate over time. The majority of people with schizophrenia have the potential to achieve long-term remission and functional recovery. The fact that some experience deterioration in functioning over time may reflect poor access, or adherence, to treatment, the effects of concurrent conditions, and social and financial impoverishment. Mental health professionals need to join with patients and their families in understanding that schizophrenia is not a malignant disease that inevitably deteriorates over time but rather one from which most people can achieve a substantial degree of recovery.

摘要

精神分裂症在历史上被认为是一种进行性疾病,这种观点最近得到了 MRI 发现的支持,即在疾病早期大脑组织会逐渐丧失。另一方面,精神分裂症康复是可能的观点越来越被消费者和家庭群体所接受。这篇综述批判性地评估了来自纵向研究的证据,包括(1)临床结果、(2)MRI 脑体积和(3)认知功能。首先,研究表明,尽管大约 25%的精神分裂症患者有较差的长期预后,但其中很少有人表现出与神经退行性疾病特征一致的功能逐渐丧失。其次,MRI 研究表明,在精神病发作的最初阶段存在微妙的发育异常,然后大脑组织体积进一步减少;然而,这些后期的减少可以用抗精神病药物、物质滥用和其他次要因素的影响来解释。第三,尽管患者与对照组相比表现出认知缺陷,但认知功能似乎不会随时间恶化。大多数精神分裂症患者都有实现长期缓解和功能恢复的潜力。一些人随着时间的推移出现功能恶化的事实可能反映了治疗的机会不足或不坚持、并发疾病的影响以及社会和经济贫困。心理健康专业人员需要与患者及其家属一起理解,精神分裂症不是一种恶性疾病,它不会随着时间的推移而不可避免地恶化,而是大多数人可以从中获得相当程度的康复。

相似文献

1
The myth of schizophrenia as a progressive brain disease.精神分裂症是一种进行性脑疾病的说法是一种谬论。
Schizophr Bull. 2013 Nov;39(6):1363-72. doi: 10.1093/schbul/sbs135. Epub 2012 Nov 20.
2
The longitudinal course of cognitive impairment in schizophrenia: an examination of data from premorbid through posttreatment phases of illness.精神分裂症认知障碍的纵向病程:对疾病前至治疗后阶段数据的考察。
J Clin Psychiatry. 2014;75 Suppl 2:8-13. doi: 10.4088/JCP.13065su1.02.
3
The early longitudinal course of cognitive deficits in schizophrenia.精神分裂症认知缺陷的早期纵向病程。
J Clin Psychiatry. 2014;75 Suppl 2(0 2):25-9. doi: 10.4088/JCP.13065.su1.06.
4
Motivational deficits in early schizophrenia: prevalent, persistent, and key determinants of functional outcome.早期精神分裂症的动机缺陷:普遍存在、持续存在且是功能结局的关键决定因素。
Schizophr Res. 2015 Aug;166(1-3):9-16. doi: 10.1016/j.schres.2015.04.040. Epub 2015 May 15.
5
Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia.长期抗精神病药物治疗与脑容量:首发精神分裂症的纵向研究
Arch Gen Psychiatry. 2011 Feb;68(2):128-37. doi: 10.1001/archgenpsychiatry.2010.199.
6
Three-year longitudinal population-based volumetric MRI study in first-episode schizophrenia spectrum patients.对首发精神分裂症谱系障碍患者进行的为期三年的基于人群的容积磁共振成像纵向研究。
Psychol Med. 2014 Jun;44(8):1591-604. doi: 10.1017/S0033291713002365. Epub 2013 Sep 26.
7
An incongruent reality: the N400 in relation to psychosis and recovery.一种不一致的现实:与精神病及康复相关的N400
Schizophr Res. 2014 Dec;160(1-3):208-15. doi: 10.1016/j.schres.2014.09.039. Epub 2014 Oct 22.
8
Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.精准医疗,首次就诊:高度个性化和基于评估的青少年心理健康管理医疗模式。
Med J Aust. 2019 Nov;211 Suppl 9:S3-S46. doi: 10.5694/mja2.50383.
9
Why are the outcomes in patients with schizophrenia so poor?为什么精神分裂症患者的预后如此之差?
J Clin Psychiatry. 2014;75 Suppl 2:20-4. doi: 10.4088/JCP.13065su1.05.
10
[What support of young presenting a first psychotic episode, when schooling is being challenged?].当学业受到挑战时,对于首次出现精神病发作的年轻人有哪些支持措施?
Encephale. 2017 Dec;43(6):570-576. doi: 10.1016/j.encep.2017.10.001. Epub 2017 Nov 8.

引用本文的文献

1
Network-based Molecular Constraints on Synaptic Density Alterations in Schizophrenia.基于网络的精神分裂症突触密度改变的分子制约因素
medRxiv. 2025 Mar 23:2025.03.22.25324465. doi: 10.1101/2025.03.22.25324465.
2
A potential mechanism for tau protein modulating in schizophrenia with transcranial direct current stimulation intervention: A randomized controlled trial.经颅直流电刺激干预下tau蛋白在精神分裂症中调节作用的潜在机制:一项随机对照试验
Bioimpacts. 2024 Jul 22;15:30274. doi: 10.34172/bi.30274. eCollection 2025.
3
Unravelling pathological ageing with brain age gap estimation in Alzheimer's disease, diabetes and schizophrenia.通过在阿尔茨海默病、糖尿病和精神分裂症中估计脑龄差距来揭示病理性衰老
Brain Commun. 2025 Mar 11;7(2):fcaf109. doi: 10.1093/braincomms/fcaf109. eCollection 2025.
4
Rethinking Schizophrenia-A Manageable Chronic Condition.重新思考精神分裂症——一种可管理的慢性病。
Can J Psychiatry. 2025 Mar;70(3):151-153. doi: 10.1177/07067437241301572. Epub 2024 Dec 10.
5
Brain Age Gap as a Predictor of Early Treatment Response and Functional Outcomes in First-Episode Schizophrenia: A Longitudinal Study: L'écart d'âge cérébral comme prédicteur de la réponse en début de traitement et des résultats fonctionnels dans un premier épisode de schizophrénie : une étude longitudinale.脑龄差距作为首发精神分裂症早期治疗反应和功能结局的预测指标:一项纵向研究:脑龄差距作为首发精神分裂症早期治疗反应和功能结局的预测指标:一项纵向研究。
Can J Psychiatry. 2025 Mar;70(3):240-250. doi: 10.1177/07067437241293981. Epub 2024 Nov 10.
6
Circulating Cell-Free Mitochondrial DNA in Plasma of Individuals with Schizophrenia and Cognitive Deficit in Mexican Population.墨西哥人群中精神分裂症和认知缺陷个体血浆中的循环游离线粒体DNA
Neuropsychiatr Dis Treat. 2024 Sep 21;20:1757-1765. doi: 10.2147/NDT.S460554. eCollection 2024.
7
Biomarkers for Psychosis: Are We There Yet? Umbrella Review of 1478 Biomarkers.精神病的生物标志物:我们做到了吗?对1478种生物标志物的综合评价
Schizophr Bull Open. 2024 Aug 30;5(1):sgae018. doi: 10.1093/schizbullopen/sgae018. eCollection 2024 Jan.
8
Neurostructural, Neurofunctional, and Clinical Features of Chronic, Untreated Schizophrenia: A Narrative Review.慢性未治疗精神分裂症的神经结构、神经功能及临床特征:一项叙述性综述
Schizophr Bull. 2025 Mar 14;51(2):366-378. doi: 10.1093/schbul/sbae152.
9
Development and Validation of Predictive Model for a Diagnosis of First Episode Psychosis Using the Multinational EU-GEI Case-control Study and Modern Statistical Learning Methods.利用欧盟多国基因与环境研究(EU-GEI)病例对照研究及现代统计学习方法开发并验证首次发作精神病诊断预测模型
Schizophr Bull Open. 2023 Mar 10;4(1):sgad008. doi: 10.1093/schizbullopen/sgad008. eCollection 2023 Jan.
10
Late 'Early Intervention in Psychosis': A Family School for Learning How to Live with Schizophrenia.晚期“精神病早期干预”:一所学习如何与精神分裂症共处的家庭学校。
Consort Psychiatr. 2021 Nov 5;2(3):3-16. doi: 10.17816/CP99. eCollection 2021.

本文引用的文献

1
Cognitive functioning in prodromal psychosis: a meta-analysis.前驱期精神病的认知功能:一项荟萃分析。
Arch Gen Psychiatry. 2012 Jun;69(6):562-71. doi: 10.1001/archgenpsychiatry.2011.1592.
2
Contrasting effects of haloperidol and lithium on rodent brain structure: a magnetic resonance imaging study with postmortem confirmation.氟哌啶醇和锂对啮齿动物大脑结构的对比影响:一项磁共振成像研究及死后确认。
Biol Psychiatry. 2012 May 15;71(10):855-63. doi: 10.1016/j.biopsych.2011.12.004. Epub 2012 Jan 15.
3
Antipsychotic prophylaxis is needed after remission from a first psychotic episode in schizophrenia patients: results from an aborted randomised trial.抗精神病药物预防在精神分裂症患者首次精神病发作缓解后是必要的:一项中止的随机试验结果。
Int J Psychiatry Clin Pract. 2011 Jun;15(2):128-34. doi: 10.3109/13651501.2010.534801. Epub 2010 Nov 30.
4
Structural brain abnormalities in first-episode psychosis: differences between affective psychoses and schizophrenia and relationship to clinical outcome.首发精神病的结构性脑异常:情感性精神病与精神分裂症的差异及其与临床结局的关系。
Bipolar Disord. 2011 Aug-Sep;13(5-6):545-55. doi: 10.1111/j.1399-5618.2011.00953.x.
5
Duration of untreated illness in schizophrenia is not associated with 5-year brain volume change.精神分裂症未治疗病程与 5 年脑容量变化无关。
Schizophr Res. 2011 Oct;132(1):84-90. doi: 10.1016/j.schres.2011.07.018. Epub 2011 Aug 10.
6
Progressive brain change in schizophrenia: a prospective longitudinal study of first-episode schizophrenia.精神分裂症的进行性脑改变:首发精神分裂症的前瞻性纵向研究。
Biol Psychiatry. 2011 Oct 1;70(7):672-9. doi: 10.1016/j.biopsych.2011.05.017. Epub 2011 Jul 23.
7
A quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia.基于人群的前瞻性研究中精神分裂症发病前智力的定量荟萃分析。
Schizophr Res. 2011 Nov;132(2-3):220-7. doi: 10.1016/j.schres.2011.06.017. Epub 2011 Jul 18.
8
Substance use and regional gray matter volume in individuals at high risk of psychosis.物质使用与精神病高危个体的区域性灰质体积。
Eur Neuropsychopharmacol. 2012 Feb;22(2):114-22. doi: 10.1016/j.euroneuro.2011.06.004. Epub 2011 Jul 8.
9
Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volume.压力和炎症会降低首发精神病患者脑源性神经营养因子的表达:导致海马体体积减小的一种途径。
J Clin Psychiatry. 2011 Dec;72(12):1677-1684. doi: 10.4088/JCP.10m06745. Epub 2011 May 18.
10
Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies.精神分裂症是否存在进行性脑改变?结构磁共振成像研究的荟萃分析。
Biol Psychiatry. 2011 Jul 1;70(1):88-96. doi: 10.1016/j.biopsych.2011.01.032. Epub 2011 Mar 31.